The US Food and Drug Administration (FDA) has cleared Molecular Designs’ SimplicityDx FluA/FluB/RSV panel, marking the company’s first cleared diagnostic assay.
The multiplex real-time reverse transcription polymerase chain reaction (RT-PCR) test identifies and differentiates influenza A, influenza B, and respiratory syncytial virus (RSV) RNA from anterior nasal swabs taken from individuals displaying symptoms of respiratory tract infection.